Renolit
301 Berkeley Dr Ste B, Swedesboro, NJ, 08085, United States
Overview
American Renolit Corporation is a plastics company that manufactures plastic films and derived products.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Consumer Goods
- Manufacturing
Investment portfolio
- Inovedis
Participated · Series A · Oct 2023
Inovedis develops the SINEFIX implant system, a device that enables refixation of the rotator cuff tendon to bone using a simplified surgical technique optimized for minimally invasive surgery. SINEFIX requires minimal instrumentation and reduces the complexity of suture management and knot tying. The implant received FDA clearance in 2023. Inovedis closed a $4M Series A to support its next commercial and clinical steps. Proceeds will be used for the commercial launch of SINEFIX in the United States and to sponsor a clinical study in Germany to generate data needed for CE marking and expansion into Europe. The company is led by Founder and CEO Lukas Flöss and co-founder/inventor Dr. Stefan Welte and is based in Albstadt, Germany.
- Kumovis
Participated · Series A · Jun 2020
Kumovis builds 3D printing systems with clean room integration aimed at healthcare and medical production. Its core product enables the medical community to process high-performance polymers in a reproducible and regulatory-compliant way. The company released the R1 3D printer in 2019, introducing an industry-specific system for decentralized clean room production. Kumovis was originally founded as a spin-off of the Technical University of Munich and is led by Stefan Leonhardt and Dr Miriam Haerst. The company is based in Munich, Germany. It recently raised funding to support market entry and further technology development. Kumovis develops 3D printers tailored to medical-technology requirements, enabling the manufacturing of individualized medical products such as patient-customized implants. Its printers focus on processing high-performance polymers like PEEK and PPSU, materials already established and approved in medical technology. The company was founded in October 2017 as a spin-off of the Technical University of Munich and is based in Munich, Germany. Kumovis raised a seven-figure seed funding round and intends to use the proceeds for the market launch of its printers. The product positioning targets regulatory and material needs specific to medical device manufacturing. The article does not disclose revenue or user metrics.
Team
No current team members are available.